More Than One in Ten Heavy Cannabis Users Experience Withdrawal After Quitting Cannabis
As the number of Americans who regularly use cannabis has climbed, so too has the number of those experiencing cannabis withdrawal symptoms.
Engineered Yeast Could Enable the Efficient Production of Pure Cannabinoids
The large scale production of all cannabinoids could soon be possible thanks to a biotech company based in Hungary.
Could Cannabis Make an Effective Dementia Treatment?
Sundial Growers and the University of Saskatchewan have just agreed to investigate the use of cannabis to treat dementia as part of 3 year agreement.
MyDx to Support Study on the Impacts of Cannabis Use in HIV Patients
The overarching goals of this study are to oinvestigate the influence of marijuana on major health outcomes and behavior in persons living with HIV in order to help guide clinical recommendations and identify risk factors for consequences.
Review Reveals Lack of Research on the Impact of Cannabis Use on Puberty
"As puberty is a critical window of physical growth and development, it is critical to fully understand what impact cannabis consumption can have." Constantine Samaan, associate professor of the Department of Pediatrics, McMaster University.
62,000 Brain Scans Used to Help Identify Drivers of Brain Aging
The lead author of the related paper commented: “Based on one of the largest brain imaging studies ever done, we can now track common disorders and behaviors that prematurely age the brain."
Teen Cannabis Use is Not Without Risk to Cognitive Development
The concurrent and lasting effects of adolescent cannabis on important cognitive functions have now been observed and appear to be more pronounced than those observed for alcohol.
PathogenDx Launches World's First Quantitative Microarray Test for Cannabis
The company says they have developed an innovative approach, leveraging microarray technology to determine the quantity of microbial content in a sample relative to a specific testing standard.
Cannabinoid Drugs Make Pain Feel 'Less Unpleasant, More Tolerable'
Cannabinoid drugs do not appear to reduce the intensity of experimental pain, but, instead, may make pain feel less unpleasant and more tolerable.
EVIO Labs Massachusetts Announces to Relocate to Framingham
The lab will move to a centrally located 5,000 square foot facility that to serve marijuana establishments statewide.
